AU2002221130A1 - Blood lipid ameliorant composition - Google Patents

Blood lipid ameliorant composition

Info

Publication number
AU2002221130A1
AU2002221130A1 AU2002221130A AU2113002A AU2002221130A1 AU 2002221130 A1 AU2002221130 A1 AU 2002221130A1 AU 2002221130 A AU2002221130 A AU 2002221130A AU 2113002 A AU2113002 A AU 2113002A AU 2002221130 A1 AU2002221130 A1 AU 2002221130A1
Authority
AU
Australia
Prior art keywords
ameliorant
composition
blood lipid
lipid
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221130A
Inventor
Tatsuhito Kondo
Masato Nakayama
Tsuneoki Ohsawa
Ippei Shimizu
Ikuo Takagi
Yasuhiro Torizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU2002221130A1 publication Critical patent/AU2002221130A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2002221130A 2000-12-14 2001-12-12 Blood lipid ameliorant composition Abandoned AU2002221130A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000379880 2000-12-14
JP2000-379880 2000-12-14
PCT/JP2001/010913 WO2002047683A1 (en) 2000-12-14 2001-12-12 Blood lipid ameliorant composition

Publications (1)

Publication Number Publication Date
AU2002221130A1 true AU2002221130A1 (en) 2002-06-24

Family

ID=18848166

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221130A Abandoned AU2002221130A1 (en) 2000-12-14 2001-12-12 Blood lipid ameliorant composition

Country Status (6)

Country Link
CN (1) CN1287787C (en)
AU (1) AU2002221130A1 (en)
CA (1) CA2430764A1 (en)
HK (1) HK1061519A1 (en)
TW (1) TWI292315B (en)
WO (1) WO2002047683A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004004774A2 (en) * 2002-07-03 2004-01-15 Esperion Therapeutics, Inc. Compositions comprising panthetine for the treatment of dyslipidemia
US20050159478A1 (en) * 2003-12-23 2005-07-21 Hunsicker Jeffrey C. Compositions containing d-tocopherol compound polybasic acid partial esters
JP5080011B2 (en) * 2005-02-28 2012-11-21 第一三共ヘルスケア株式会社 Composition for increasing glutathione peroxidase activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019891B2 (en) * 1978-12-01 1985-05-18 第一製薬株式会社 Drug-induced fatty liver agent
JPS5869813A (en) * 1981-10-23 1983-04-26 Sogo Yatsukou Kk Serum lipid depressant
JPS6041611A (en) * 1983-08-17 1985-03-05 Sankyo Co Ltd Blood lipid improving agent
US5662934A (en) * 1993-01-05 1997-09-02 Najarian; Thomas Compositions and methods for lowering cholesterol while maintaining antioxidant levels
JP2000508659A (en) * 1996-04-17 2000-07-11 メルク エンド カンパニー インコーポレーテッド Combination therapy to reduce cardiovascular disease-related risks
EP0933080A4 (en) * 1996-05-29 2002-02-27 Taisho Pharmaceutical Co Ltd Remedy or preventive for hyperlipemia

Also Published As

Publication number Publication date
CN1287787C (en) 2006-12-06
WO2002047683A1 (en) 2002-06-20
HK1061519A1 (en) 2004-09-24
TWI292315B (en) 2008-01-11
CA2430764A1 (en) 2002-06-20
CN1489464A (en) 2004-04-14

Similar Documents

Publication Publication Date Title
AU2001241963A1 (en) Improved medical procedure
AU2001267851A1 (en) Oxygen-containing ophthalmic composition
AU2001232360A1 (en) Medical instrument
AU2001260327A1 (en) Chair
AU2001295657A1 (en) Formulation containing wax-esters
AU2001259702A1 (en) Tissue regrafting
AU4439701A (en) Patient support
AU2001233208A1 (en) Human sulfatases
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001294132A1 (en) Alcohol-free perfuming composition
AU2002221131A1 (en) Blood lipid ameliorant composition
AU2001241098A1 (en) Composition
AUPQ761100A0 (en) Lipophilic medicament
AU2001264631A1 (en) Medical instrument
AU2002227925A1 (en) Human beta-defensin-3
AU2001275201A1 (en) Acne-treating composition
AU4085201A (en) Pharmaceutical composition
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001247841A1 (en) Medical procedure
AU9517501A (en) Composition containing leishmania LIP2A
AU2001287852A1 (en) Composition
AU2001252200A1 (en) Chair
AU2002221130A1 (en) Blood lipid ameliorant composition
AU2001295991A1 (en) Compositions for improving lipids in blood